Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Mono-Centre Randomised Controlled Trial to Investigate the Feasibility of Blood Glucose Control With the Software-Algorithm eMPC (Enhanced Model Predictive Control) Via the Arterial-Intravenous Route in Patients at the Medical Intensive Care Unit.

NCT00460252 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT00460252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Mono-Centre Randomised Controlled Trial to Investigate the Feasibility of Blood Glucose Control With the Software-Algorithm eMPC (Enhanced Model Predictive Control) Via the Arterial-Intravenous Route in Patients at the Medical Intensive Care Unit.
Lead sponsor
Medical University of Graz
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2006
Completion date
November 30, 2006
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill patients, hyperglycemia, mechanical ventilation